Evaluation of apigenin using in vitro cytochalasin blocked micronucleus assay

Sanjeev Noel1, Madhu Kasinathan, Srikanta Kumar Rath

  • 1Genotoxicity Laboratory, Division of Toxicology, Central Drug Research Institute, M.G. Marg, Lucknow 226 001, Uttar Pradesh, India.

Insights

High doses of the flavonoid apigenin may pose a genotoxic risk. This study found apigenin induced micronuclei in human lymphocytes, suggesting potential mutagenic effects at high concentrations.

Area of Science:

  • Environmental toxicology
  • Molecular biology
  • Biochemistry

Background:

  • Flavonoids exhibit dual roles, potentially reducing oxidative DNA damage while also showing clastogenic effects at high doses.
  • Contradictory findings exist regarding flavonoid genotoxicity, necessitating further investigation into specific compounds like apigenin.

Purpose of the Study:

  • To evaluate the genotoxic potential of apigenin, a plant-derived flavonoid, in human peripheral lymphocytes.
  • To determine if apigenin induces chromosomal damage in a dose-dependent manner.

Main Methods:

  • Utilized the cytochalasin-B blocked micronucleus (CBMN) assay.
  • Exposed peripheral human lymphocytes to varying concentrations of apigenin (10, 33, and 100 microM).

Main Results:

  • Apigenin demonstrated a dose-dependent induction of micronuclei in human lymphocytes.
  • The results indicate a potential genotoxic hazard associated with high apigenin exposure.

Conclusions:

  • Flavonoids, including apigenin, can exhibit clastogenic effects at high concentrations.
  • The genotoxic outcome of flavonoids may depend on dosage and individual physiological factors, potentially acting as mutagens or pro-oxidants.

Related Concept Videos